WPRIM Management System> DCMS> Journal of Neurogastroenterology and Motility> 2021> 27> 2

Volume: 27 Issue: 2

1. There Is Something More Important Than Proximal Reflux Episode in the Development of Post-reflux Swallow-induced Peristaltic Wave Page:305—306
2. Transient Receptor Potential Canonical 4 Channel in Interstitial Cells of Cajal as a Target for Control of Gastrointestinal Motility Page:302—304
3. Colonic Gene Expression and Fecal Microbiota in Diarrhea-predominant Irritable Bowel Syndrome:Increased Toll-like Receptor 4 but Minimal Inflammation and no Response to Mesalazine Page:279—291
4. High-fat Diet Enhances Gastric Contractility, but Abolishes Nesfatin-1-induced Inhibition of Gastric Emptying Page:265—278
5. A Resting-state Functional Magnetic Resonance Imaging Study of Whole-brain Functional Connectivity of Voxel Levels in Patients With Irritable Bowel Syndrome With Depressive Symptoms Page:248—256
6. Efficacy of S-pantoprazole 10 mg in the Symptom Control of Non-erosive Reflux Disease:A Phase III Placebo-controlled Trial Page:223—230
7. Esophageal Motility Patterns After Peroral Endoscopic Myotomy in Patients With Achalasia Page:205—214
8. Simultaneous Evaluation of Laryngopharyngeal Reflux and Swallowing Function Using Hypopharyngeal Multichannel Intraluminal Impedance Measurements in Neurologically Impaired Patients Page:198—204
9. Impact of Overlapping Functional Gastrointestinal Disorders on the Quality of Life in Patients With Gastroesophageal Reflux Disease Page:176—184
10. A Systematic Review and Meta-analysis of Randomized Control Trials: Combination Treatment With Proton Pump Inhibitor Plus Prokinetic for Gastroesophageal Reflux Disease Page:165—175
11. Inflammation and Overlap of Irritable Bowel Syndrome and Functional Dyspepsia Page:153—164
12. Integrated Relaxation Pressure During Swallowing:An Ever-changing Metric Page:151—152
13. What Is the Difference in Characteristics Between Belching Disorder and Gastroesophageal Reflux Disease With Belching? Centering Around Supragastric Belching Page:149—150
14. Impaired Colonic Contractility and Intestinal Permeability in Symptomatic Uncomplicated Diverticular Disease Page:292—301
15. Impact of Serotonin Transporter Gene Polymorphism on Gut Motility in Patients With Type 2 Diabetes Mellitus Page:240—247
16. Usefulness of Endoscopic Hill Grade in Evaluating Children Suspected of Having Gastroesophageal Reflux Disease Page:191—197
17. Alteration in Integrated Relaxation Pressure During Successive Swallows in Subjects With Normal Manometry Versus Those With Esophagogastric Junction Outflow Obstruction Page:185—190
18. Characteristics of Symptomatic Belching in Patients With Belching Disorder and Patients Who Exhibit Gastroesophageal Reflux Disease With Belching Page:231—239
19. Lactose Sensitivity and Lactose Malabsorption:The 2 Faces of Lactose Intolerance Page:257—264
20. The Influence of Gastroesophageal Reflux Disease on Daytime Sleepiness and Depressive Symptom in Patients With Obstructive Sleep Apnea Page:215—222
21. There Is Something More Important Than Proximal Reflux Episode in the Development of Post-reflux Swallow-induced Peristaltic Wave Page:305—306
22. Transient Receptor Potential Canonical 4 Channel in Interstitial Cells of Cajal as a Target for Control of Gastrointestinal Motility Page:302—304
23. Colonic Gene Expression and Fecal Microbiota in Diarrhea-predominant Irritable Bowel Syndrome:Increased Toll-like Receptor 4 but Minimal Inflammation and no Response to Mesalazine Page:279—291
24. High-fat Diet Enhances Gastric Contractility, but Abolishes Nesfatin-1-induced Inhibition of Gastric Emptying Page:265—278
25. A Resting-state Functional Magnetic Resonance Imaging Study of Whole-brain Functional Connectivity of Voxel Levels in Patients With Irritable Bowel Syndrome With Depressive Symptoms Page:248—256
26. Efficacy of S-pantoprazole 10 mg in the Symptom Control of Non-erosive Reflux Disease:A Phase III Placebo-controlled Trial Page:223—230
27. Esophageal Motility Patterns After Peroral Endoscopic Myotomy in Patients With Achalasia Page:205—214
28. Simultaneous Evaluation of Laryngopharyngeal Reflux and Swallowing Function Using Hypopharyngeal Multichannel Intraluminal Impedance Measurements in Neurologically Impaired Patients Page:198—204
29. Impact of Overlapping Functional Gastrointestinal Disorders on the Quality of Life in Patients With Gastroesophageal Reflux Disease Page:176—184
30. A Systematic Review and Meta-analysis of Randomized Control Trials: Combination Treatment With Proton Pump Inhibitor Plus Prokinetic for Gastroesophageal Reflux Disease Page:165—175
31. Inflammation and Overlap of Irritable Bowel Syndrome and Functional Dyspepsia Page:153—164
32. Integrated Relaxation Pressure During Swallowing:An Ever-changing Metric Page:151—152
33. What Is the Difference in Characteristics Between Belching Disorder and Gastroesophageal Reflux Disease With Belching? Centering Around Supragastric Belching Page:149—150
34. Impaired Colonic Contractility and Intestinal Permeability in Symptomatic Uncomplicated Diverticular Disease Page:292—301
35. Impact of Serotonin Transporter Gene Polymorphism on Gut Motility in Patients With Type 2 Diabetes Mellitus Page:240—247
36. Usefulness of Endoscopic Hill Grade in Evaluating Children Suspected of Having Gastroesophageal Reflux Disease Page:191—197
37. Alteration in Integrated Relaxation Pressure During Successive Swallows in Subjects With Normal Manometry Versus Those With Esophagogastric Junction Outflow Obstruction Page:185—190
38. Characteristics of Symptomatic Belching in Patients With Belching Disorder and Patients Who Exhibit Gastroesophageal Reflux Disease With Belching Page:231—239
39. Lactose Sensitivity and Lactose Malabsorption:The 2 Faces of Lactose Intolerance Page:257—264
40. The Influence of Gastroesophageal Reflux Disease on Daytime Sleepiness and Depressive Symptom in Patients With Obstructive Sleep Apnea Page:215—222

©2019 - Present World Health Organization Regional Office for the Western Pacific. All Rights Reserved.